ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New Jersey » Endocrinology, Diabetes Metabolism

Top Endocrinology, Diabetes Metabolism Prescribers in New Jersey

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
CARL VICTOR MD

Endocrinology, Diabetes Metabolism

11,076

$1.16M

519
419 are 65+

7%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 52%

$104
Average prescription price

Avg: $167

PUDCHONG SRISETHNIL M.D., F.A.C.E.

Endocrinology, Diabetes Metabolism

10,630

$780K

526
413 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 52%

$73
Average prescription price

Avg: $167

JOSEPH FALLON M.D.

Endocrinology, Diabetes Metabolism

9,588

$1.55M

751
629 are 65+

3%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 52%

$161
Average prescription price

Avg: $167

ROBERT FUHRMAN M.D.

Endocrinology, Diabetes Metabolism

9,026

$813K

456
410 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 52%

$90
Average prescription price

Avg: $167

JOSEPH BIRNBAUM MD

Endocrinology, Diabetes Metabolism

7,372

$1.4M

699
592 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

56%
prescriptions for brand name drugs

Avg: 52%

$189
Average prescription price

Avg: $167

MARGARET CIECHANOWSKA MD

Endocrinology, Diabetes Metabolism

7,255

$850K

492
381 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

44%
prescriptions for brand name drugs

Avg: 52%

$117
Average prescription price

Avg: $167

JOSEPH SCHWARTZ MD

Endocrinology, Diabetes Metabolism

7,073

$879K

691
579 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 52%

$124
Average prescription price

Avg: $167

HELEN SLONE M.D.

Endocrinology, Diabetes Metabolism

6,658

$1.39M

911
677 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 52%

$209
Average prescription price

Avg: $167

RICHARD BERKOWITZ MD

Endocrinology, Diabetes Metabolism

6,347

$992K

405
360 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 52%

$156
Average prescription price

Avg: $167

KENNETH ORDENE MD

Endocrinology, Diabetes Metabolism

6,172

$1.31M

613
538 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

54%
prescriptions for brand name drugs

Avg: 52%

$212
Average prescription price

Avg: $167

RONALD VILLANUEVA MD

Endocrinology, Diabetes Metabolism

5,853

$1.37M

730
595 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

60%
prescriptions for brand name drugs

Avg: 52%

$233
Average prescription price

Avg: $167

DANIEL ROSENBAUM M.D.

Endocrinology, Diabetes Metabolism

5,718

$1.09M

550
404 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 52%

$191
Average prescription price

Avg: $167

MURRAY LAS

Endocrinology, Diabetes Metabolism

5,710

$814K

414
329 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 52%

$142
Average prescription price

Avg: $167

ARA APELIAN MD

Endocrinology, Diabetes Metabolism

5,674

$560K

283
229 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 52%

$99
Average prescription price

Avg: $167

JOSEPH RODRIGUEZ M.D.

Endocrinology, Diabetes Metabolism

5,463

$1.09M

704
625 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

57%
prescriptions for brand name drugs

Avg: 52%

$200
Average prescription price

Avg: $167

SYED RIZVI MD

Endocrinology, Diabetes Metabolism

5,299

$1.17M

397
247 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

14%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

60%
prescriptions for brand name drugs

Avg: 52%

$222
Average prescription price

Avg: $167

DANUTA SILBER MD PHD

Endocrinology, Diabetes Metabolism

5,255

$711K

381
307 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 52%

$135
Average prescription price

Avg: $167

DAVID GARBOWIT M.D.

Endocrinology, Diabetes Metabolism

5,205

$865K

483
416 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 52%

$166
Average prescription price

Avg: $167

ADAM KELMAN M.D.

Endocrinology, Diabetes Metabolism

5,140

$897K

509
451 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 52%

$174
Average prescription price

Avg: $167

CRISTINA XENACHIS M.D.

Endocrinology, Diabetes Metabolism

5,098

$919K

395
297 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

53%
prescriptions for brand name drugs

Avg: 52%

$180
Average prescription price

Avg: $167

RHODA COBIN M.D.

Endocrinology, Diabetes Metabolism

4,934

$672K

556
493 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

50%
prescriptions for brand name drugs

Avg: 52%

$136
Average prescription price

Avg: $167

MITCHELL SILVERMAN MD

Endocrinology, Diabetes Metabolism

4,834

$870K

338
263 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

50%
prescriptions for brand name drugs

Avg: 52%

$180
Average prescription price

Avg: $167

JACQUES TOHME MD

Endocrinology, Diabetes Metabolism

4,723

$677K

826
744 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

1%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

50%
prescriptions for brand name drugs

Avg: 52%

$143
Average prescription price

Avg: $167

SAMUEL DOWER MD

Endocrinology, Diabetes Metabolism

4,667

$652K

522
462 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 52%

$140
Average prescription price

Avg: $167

LOUIS HAENEL D.O.

Endocrinology, Diabetes Metabolism

4,654

$910K

708
548 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 52%

$196
Average prescription price

Avg: $167

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank